Try a new search

Format these results:

Searched for:

person:ettina02

in-biosketch:true

Total Results:

165


Does a psychiatric history play a role in the development of psychiatric adverse events to perampanel… and to placebo?

Kanner, Andres M; Patten, Anna; Ettinger, Alan B; Helmstaedter, Christoph; Meador, Kimford J; Malhotra, Manoj
OBJECTIVE:The purpose of this study was to establish whether a past psychiatric history could play a role in the development of psychiatric treatment-emergent adverse events (PTEAEs) in patients randomized to perampanel (PER) or placebo. METHODS:The development of PTEAEs was compared between patients with/without a psychiatric history in a post hoc analysis from four randomized placebo-controlled trials (RPCTs) of PER (304/305/306/335) in patients with treatment-resistant focal epilepsy. RESULTS:Among the 2,187 patients enrolled in the RPCTs, 352 (16.1%) had a psychiatric history (PER n = 244; placebo n = 108), while 1835 patients (83.9%) did not (PER n = 1325; placebo n = 510). Compared to patients without a psychiatric history, those with a positive history reported more PTEAEs for both patients randomized to PER (11.8% vs. 29.9%, p < 0.01) or to placebo (9.2% vs. 19.4%, p < 0.01). The prevalence of PTEAEs was not higher among patients randomized to 2 mg and 4 mg/day doses than placebo in both those with and without psychiatric history. Rather, the higher prevalence rates were among subjects randomized to 8 mg (29.8%) and 12 mg (36.4%) PER doses in patients with a past psychiatric history. SIGNIFICANCE:A psychiatric history appears to increase the risk of PTEAEs in patients randomized to placebo and to PER at doses of 8 and 12 mg/day. It should be identified in all patients considered for treatment with PER, particularly when prescribed at doses above 4 mg/day.
PMID: 34735963
ISSN: 1525-5069
CID: 5327502

Musical components important for the Mozart K448 effect in epilepsy

Quon, Robert J; Casey, Michael A; Camp, Edward J; Meisenhelter, Stephen; Steimel, Sarah A; Song, Yinchen; Testorf, Markus E; Leslie, Grace A; Bujarski, Krzysztof A; Ettinger, Alan B; Jobst, Barbara C
There is growing evidence for the efficacy of music, specifically Mozart's Sonata for Two Pianos in D Major (K448), at reducing ictal and interictal epileptiform activity. Nonetheless, little is known about the mechanism underlying this beneficial "Mozart K448 effect" for persons with epilepsy. Here, we measured the influence that K448 had on intracranial interictal epileptiform discharges (IEDs) in sixteen subjects undergoing intracranial monitoring for refractory focal epilepsy. We found reduced IEDs during the original version of K448 after at least 30-s of exposure. Nonsignificant IED rate reductions were witnessed in all brain regions apart from the bilateral frontal cortices, where we observed increased frontal theta power during transitions from prolonged musical segments. All other presented musical stimuli were associated with nonsignificant IED alterations. These results suggest that the "Mozart K448 effect" is dependent on the duration of exposure and may preferentially modulate activity in frontal emotional networks, providing insight into the mechanism underlying this response. Our findings encourage the continued evaluation of Mozart's K448 as a noninvasive, non-pharmacological intervention for refractory epilepsy.
PMCID:8446029
PMID: 34531410
ISSN: 2045-2322
CID: 5327492

40-Hz auditory stimulation for intracranial interictal activity: A pilot study

Quon, Robert J; Leslie, Grace A; Camp, Edward J; Meisenhelter, Stephen; Steimel, Sarah A; Song, Yinchen; Ettinger, Alan B; Bujarski, Krzysztof A; Casey, Michael A; Jobst, Barbara C
OBJECTIVES/OBJECTIVE:To study the effects of auditory stimuli on interictal epileptiform discharge (IED) rates evident with intracranial monitoring. MATERIALS AND METHODS/METHODS:Eight subjects undergoing intracranial EEG monitoring for refractory epilepsy participated in this study. Auditory stimuli consisted of a 40-Hz tone, a 440-Hz tone modulated by a 40-Hz sinusoid, Mozart's Sonata for Two Pianos in D Major (K448), and K448 modulated by a 40-Hz sinusoid (modK448). Subjects were stratified into high- and low-IED rate groups defined by baseline IED rates. Subject-level analyses identified individual responses to auditory stimuli, discerned specific brain regions with significant reductions in IED rates, and examined the influence auditory stimuli had on whole-brain sigma power (12-16 Hz). RESULTS:All subjects in the high baseline IED group had a significant 35.25% average reduction in IEDs during the 40-Hz tone; subject-level reductions localized to mesial and lateral temporal regions. Exposure to Mozart K448 showed significant yet less homogeneous responses. A post hoc analysis demonstrated two of the four subjects with positive IED responses had increased whole-brain power at the sigma frequency band during 40-Hz stimulation. CONCLUSIONS:Our study is the first to evaluate the relationship between 40-Hz auditory stimulation and IED rates in refractory epilepsy. We reveal that 40-Hz auditory stimuli may be a noninvasive adjunctive intervention to reduce IED burden. Our pilot study supports the future examination of 40-Hz auditory stimuli in a larger population of subjects with high baseline IED rates.
PMCID:8832987
PMID: 33893999
ISSN: 1600-0404
CID: 5327482

Synopsis of neurology, psychiatry and related systemic disorders

Ettinger, Alan B; Weisbrot, Deborah M; Gallimore, Casey
Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2019
Extent: xxii, 835 p. ; 26 cm
ISBN: 9781107069565
CID: 5327682

Transplant-related disorders

Chapter by: Garg, R; Chawla, J; Ettinger, Alan B
in: Synopsis of neurology, psychiatry and related systemic disorders by Ettinger, Alan B; Weisbrot, Deborah M; Gallimore, Casey [Eds]
Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2019
pp. ?-
ISBN: 9781107069565
CID: 5363502

Substance abuse

Chapter by: Golzad, M; Rentas, F; Ettinger, Alan B
in: Synopsis of neurology, psychiatry and related systemic disorders by Ettinger, Alan B; Weisbrot, Deborah M; Gallimore, Casey [Eds]
Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2019
pp. ?-
ISBN: 9781107069565
CID: 5363492

Metabolic disorders. Part 2

Chapter by: Patel, C; Patel, P; Ettinger, Alan B
in: Synopsis of neurology, psychiatry and related systemic disorders by Ettinger, Alan B; Weisbrot, Deborah M; Gallimore, Casey [Eds]
Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2019
pp. ?-
ISBN: 9781107069565
CID: 5363482

Preface

Chapter by: Ettinger, Alan B; Weisbrot, DM; Gallimore, DM
in: Synopsis of neurology, psychiatry and related systemic disorders by Ettinger, Alan B; Weisbrot, Deborah M; Gallimore, Casey [Eds]
Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2019
pp. ?-
ISBN: 9781107069565
CID: 5363532

Infectious disorders. Part 2

Chapter by: Vilceus, A; Vilceus, N; Ettinger, Alan B
in: Synopsis of neurology, psychiatry and related systemic disorders by Ettinger, Alan B; Weisbrot, Deborah M; Gallimore, Casey [Eds]
Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2019
pp. ?-
ISBN: 9781107069565
CID: 5363472

Neurodegenerative disorders

Chapter by: Altalib, HH; Ayora, P; Faqsharaki-Zadeh, A; Ettinger, Alan B
in: Synopsis of neurology, psychiatry and related systemic disorders by Ettinger, Alan B; Weisbrot, Deborah M; Gallimore, Casey [Eds]
Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2019
pp. ?-
ISBN: 9781107069565
CID: 5363512